Efficacy of High-Dose, Rapid, Hepatitis A and B Vaccination Schedules in Patients With Cirrhosis

Alan J. Wigg, Rachel Wundke, Rosemary McCormick, Kate R. Muller, Jeyamani Ramachandran, Sumudu K. Narayana, Richard J. Woodman

    Research output: Contribution to journalShort surveypeer-review

    2 Citations (Scopus)

    Abstract

    Patients with cirrhosis have increased morbidity from hepatitis A virus (HAV) and hepatitis B virus (HBV) infections, and vaccination against these infections is an important standard of care. 1,2 However, vaccination in patients with cirrhosis is hindered by immune dysfunction and there is limited high-quality literature available. The aim of this work therefore was to compare immune responses of standard dose (SD) with high-dose accelerated (HDA) vaccination in cirrhotic patients.

    Original languageEnglish
    Pages (from-to)1210-1212.e1
    Number of pages3
    JournalClinical Gastroenterology and Hepatology
    Volume17
    Issue number6
    DOIs
    Publication statusPublished - 1 May 2019

    Fingerprint Dive into the research topics of 'Efficacy of High-Dose, Rapid, Hepatitis A and B Vaccination Schedules in Patients With Cirrhosis'. Together they form a unique fingerprint.

    Cite this